citalopram has been researched along with Pregnancy in 86 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Even though the sample size was limited, results from this prospective clinical trial suggest uncomplicated pregnancy outcome in mothers using citalopram during pregnancy and minimal exposure of the infants to citalopram during lactation." | 9.10 | Citalopram in pregnancy and lactation. ( Ekblad, S; Ekblad, U; Heikkinen, T; Kero, P; Laine, K, 2002) |
| "MEDLINE and PubMed databases were searched for English language articles by using the following keywords: escitalopram, selective serotonin reuptake inhibitors, major malformations, perinatal complications, pregnancy, and breastfeeding." | 8.88 | The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review. ( Bellantuono, C; Bozzi, F; Catena-Dell'Osso, M; Orsolini, L, 2012) |
| "Treatment of major depression disorder with Selective serotonin reuptake inhibitors (SSRIs), such as citalopram (CTM), during pregnancy effects on the neurological trajectory of the offspring and induces enduring consequences, notably emotional and cognitive impairment." | 8.12 | Prenatal exposure of citalopram elicits depression-like and anxiety-like behaviors and alteration of morphology and protein expression of medial prefrontal cortex in young adult mice. ( Butt, MU; Du, L; Jia, M; Wang, Q; Wang, Y; Wu, J; Zahra, A, 2022) |
| " A treatment with escitalopram reversed depression-like behavior accompanied by reductions in BDNF levels in serum and the nucleus accumbens, while a treatment with blonanserin ameliorated abnormal social interaction behavior with reductions in serum BDNF levels." | 7.91 | Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens. ( Deriha, K; Furuse, K; Hashiguchi, H; Hashimoto, E; Ishii, T; Kawanishi, C; Kigawa, Y; Shiraishi, M; Tayama, M; Ukai, W, 2019) |
| "Neonatal abstinence syndrome (NAS) due to prenatally exposure to citalopram can develop during the first days of life even with low dose of drug exposure." | 7.85 | Neonatal abstinence syndrome due to prenatally citalopram exposure: A case report. ( Bas, AY; Celik, IH; Demirel, N; Erol, S; Ozcan, B, 2017) |
| " Using maternal separation (MS), a paradigm of early adversity, we investigated the effects of adolescent (PND 33-54) escitalopram (ES; 10mg/kg) exposure on depression- and anxiety-like behaviours and the levels of inflammatory cytokines (interleukin [IL]-1β, tumor necrosis factor [TNF]-α, and IL-10) in the ventral hippocampus (HPV), prefrontal cortex (PFC), and serum in adult (PND 61) male offspring mice." | 7.85 | Adolescent escitalopram prevents the effects of maternal separation on depression- and anxiety-like behaviours and regulates the levels of inflammatory cytokines in adult male mice. ( Dong, X; Geng, Z; Jin, Y; Li, N; Li, X; Lin, Y; Liu, M; Sun, A; Wang, Q; Wang, Y, 2017) |
| " The current study investigated whether administration of citalopram to pregnant rats could prevent anxiety and depressive-like behaviour induced by gestational stress in their offspring, and restore the expression of serotonin 1A autoreceptors in GABAergic interneurons in the medial prefrontal cortex and dorsal raphe nuclei in males, and of corticotropin-releasing factor type 2 receptors in GABAergic interneurons in the dorsal raphe nuclei in females." | 7.83 | Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring. ( Shoham, S; Weinstock, M; Zohar, I, 2016) |
| "These data indicate that: (1) clinically relevant antidepressant treatment during human pregnancy can be modeled in rats using escitalopram; (2) chronic mild stress can be delivered in a manner that does not compromise fetal viability; and (3) neither of these prenatal treatments substantially altered maternal care post parturition." | 7.79 | Prenatal exposure to escitalopram and/or stress in rats: a prenatal stress model of maternal depression and its treatment. ( Boss-Williams, KA; Bourke, CH; Capello, CF; Owens, MJ; Rogers, SM; Stowe, ZN; Weiss, JM; Yu, ML, 2013) |
| "A woman treated with citalopram during the entirety of her pregnancy bore a child with Hirschsprung's disease." | 7.79 | [Citalopram taken during pregnancy and the child born with Hirschsprung's disease]. ( Nielsen, SW; Qvist, N, 2013) |
| "We describe the case of a pregnancy healthy outcome after in utero consecutive exposure to lamotrigine and citalopram." | 7.74 | Consecutive exposure to lamotrigine and citalopram during pregnancy. ( Gentile, S; Vozzi, F, 2007) |
| "A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described." | 7.74 | Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram. ( Carter, BS; Potts, AL; Shenai, JP; Young, KL, 2007) |
| "Citalopram use during the period of embryogenesis in pregnancy is not associated with an apparent major teratogenic risk." | 7.73 | Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. ( Einarson, A; Koren, G; Sarkissian, L; Shuhaiber, S; Sivojelezova, A, 2005) |
| "The median daily dosage of citalopram was 20mg (Q1: 10mg, Q3: 20mg; range 10-40mg)." | 5.46 | Pregnancy exposure to citalopram - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. ( Goecke, TW; Gründer, G; Janssen, G; Paulzen, M; Schoretsanitis, G; Stickeler, E; Stingl, JC, 2017) |
| "Escitalopram is a serotonin reuptake inhibitor prescribed for depression and anxiety." | 5.38 | Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. ( Einarson, A; Einarson, T; Klieger-Grossmann, C; Koren, G; Panchaud, A; Pistelli, A; Weitzner, B, 2012) |
| "Bupropion's efficacy for smoking cessation in pregnant women is unknown." | 5.14 | The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse. ( Brigham, EP; Chisolm, MS; Jones, HE; Strain, EC; Tuten, M, 2010) |
| " Across pregnancy and postpartum, the mean dose-corrected plasma concentrations (L/D ratios) of S- and R-citalopram and S-sertraline, and the corresponding primary chiral metabolites S- and R-desmethylcitalopram and N-desmethylsertra-line were assessed." | 5.13 | Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. ( Helsel, JC; Perel, JM; Sit, DK; Wisner, KL, 2008) |
| "Even though the sample size was limited, results from this prospective clinical trial suggest uncomplicated pregnancy outcome in mothers using citalopram during pregnancy and minimal exposure of the infants to citalopram during lactation." | 5.10 | Citalopram in pregnancy and lactation. ( Ekblad, S; Ekblad, U; Heikkinen, T; Kero, P; Laine, K, 2002) |
| "We performed a search for the English language literature indexed on MEDLINE/PubMed for the period 2012 to 2017, using the following key terms: fluoxetine, prozac, paxil, oxactin, paroxetine, seroxat, sertraline, lustral, citalopram, cipramil, escitalopram, cipralex, fluvoxamine, faverin, with 'pregnant woman', 'pregnant women', pregnancy." | 4.95 | What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. ( Agius, M; Ripullone, K; Womersley, K, 2017) |
| "MEDLINE and PubMed databases were searched for English language articles by using the following keywords: escitalopram, selective serotonin reuptake inhibitors, major malformations, perinatal complications, pregnancy, and breastfeeding." | 4.88 | The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review. ( Bellantuono, C; Bozzi, F; Catena-Dell'Osso, M; Orsolini, L, 2012) |
| "The recent clinical studies on hypericum extract support the present indications for its use in mild to moderate depression and depressive episodes." | 4.84 | [New developments in hypericum extracts: data on efficacy and interactions]. ( Kraft, K, 2007) |
| "Treatment of major depression disorder with Selective serotonin reuptake inhibitors (SSRIs), such as citalopram (CTM), during pregnancy effects on the neurological trajectory of the offspring and induces enduring consequences, notably emotional and cognitive impairment." | 4.12 | Prenatal exposure of citalopram elicits depression-like and anxiety-like behaviors and alteration of morphology and protein expression of medial prefrontal cortex in young adult mice. ( Butt, MU; Du, L; Jia, M; Wang, Q; Wang, Y; Wu, J; Zahra, A, 2022) |
| "Plasma levels of Sertraline, Citalopram and Escitalopram were more frequently in range in late pregnancy when compared to other drugs." | 4.02 | Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affec ( Bosi, MF; Cafaro, R; Cetin, I; Clementi, E; Colombo, A; Dell'Osso, B; Di Bernardo, I; Giordano, F; Giorgetti, F; Pileri, P; Varinelli, A; Viganò, CA, 2021) |
| "Urinary SSRIs (fluoxetine, sertraline, escitalopram/citalopram) were measured while trying to conceive and, for women who became pregnant, at weeks 0, 4, and 8 of pregnancy." | 3.96 | Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss. ( Flannagan, KS; Kim, K; Mumford, SL; Perkins, NJ; Radoc, JG; Schisterman, EF; Silver, RM; Sjaarda, LA, 2020) |
| " A treatment with escitalopram reversed depression-like behavior accompanied by reductions in BDNF levels in serum and the nucleus accumbens, while a treatment with blonanserin ameliorated abnormal social interaction behavior with reductions in serum BDNF levels." | 3.91 | Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens. ( Deriha, K; Furuse, K; Hashiguchi, H; Hashimoto, E; Ishii, T; Kawanishi, C; Kigawa, Y; Shiraishi, M; Tayama, M; Ukai, W, 2019) |
| "Citalopram (CTM), a selective serotonin reuptake inhibitor (SSRI), has been widely used to treat panic disorders, such as depression which is one of the most disabling, yet common, psychiatric disorders." | 3.91 | Exposure to prenatal antidepressant alters medial prefrontal-striatal synchronization in mice. ( Chen, Y; Jiang, J; Long, C; Yang, L; Zahra, A; Zheng, Y, 2019) |
| "For paroxetine and fluvoxamine the pronounced decline in maternal drug serum concentrations in pregnancy may necessitate a dose increase of about 100% during the third trimester in order to maintain stable concentrations." | 3.85 | Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. ( Brekke, M; Molden, E; Skogvoll, E; Spigset, O; Westin, AA, 2017) |
| " Using maternal separation (MS), a paradigm of early adversity, we investigated the effects of adolescent (PND 33-54) escitalopram (ES; 10mg/kg) exposure on depression- and anxiety-like behaviours and the levels of inflammatory cytokines (interleukin [IL]-1β, tumor necrosis factor [TNF]-α, and IL-10) in the ventral hippocampus (HPV), prefrontal cortex (PFC), and serum in adult (PND 61) male offspring mice." | 3.85 | Adolescent escitalopram prevents the effects of maternal separation on depression- and anxiety-like behaviours and regulates the levels of inflammatory cytokines in adult male mice. ( Dong, X; Geng, Z; Jin, Y; Li, N; Li, X; Lin, Y; Liu, M; Sun, A; Wang, Q; Wang, Y, 2017) |
| "Neonatal abstinence syndrome (NAS) due to prenatally exposure to citalopram can develop during the first days of life even with low dose of drug exposure." | 3.85 | Neonatal abstinence syndrome due to prenatally citalopram exposure: A case report. ( Bas, AY; Celik, IH; Demirel, N; Erol, S; Ozcan, B, 2017) |
| " Despite extended residual persistence of dichlorodiphenyltrichloroethane (DDT) in the environment, the mechanisms of perinatal actions of DDT that could account for adult-onset of depression are largely unknown." | 3.85 | Depressive-like effect of prenatal exposure to DDT involves global DNA hypomethylation and impairment of GPER1/ESR1 protein levels but not ESR2 and AHR/ARNT signaling. ( Grochowalski, A; Kajta, M; Lason, W; Litwa, E; Nalepa, I; Rogóż, Z; Rzemieniec, J; Wnuk, A; Wojtowicz, AK; Zelek-Molik, A, 2017) |
| " The current study investigated whether administration of citalopram to pregnant rats could prevent anxiety and depressive-like behaviour induced by gestational stress in their offspring, and restore the expression of serotonin 1A autoreceptors in GABAergic interneurons in the medial prefrontal cortex and dorsal raphe nuclei in males, and of corticotropin-releasing factor type 2 receptors in GABAergic interneurons in the dorsal raphe nuclei in females." | 3.83 | Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring. ( Shoham, S; Weinstock, M; Zohar, I, 2016) |
| "The objective of the current study is to determine whether the increased anxiety of prenatally stressed (PS) rats of both sexes is associated with changes in 5HT1A and CRF type 2 receptors (5HT1AR and CRFR2) in the prefrontal cortex (PFC)-dorsal raphe nuclei (DRN) axis, and how these are affected by chronic treatment with citalopram (10 mg/kg/day)." | 3.81 | Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram. ( Dosoretz-Abittan, L; Shoham, S; Weinstock, M; Zohar, I, 2015) |
| "Our results provide confirmatory evidence that citalopram exposure is associated with cellular and morphological alterations of the craniofacial complex, which may have important implications for use during pregnancy." | 3.80 | Selective serotonin reuptake inhibitor exposure alters osteoblast gene expression and craniofacial development in mice. ( Cray, JJ; Elsalanty, M; Howie, RN; Parsons, TE; Weinberg, SM; Yu, JC, 2014) |
| "A woman treated with citalopram during the entirety of her pregnancy bore a child with Hirschsprung's disease." | 3.79 | [Citalopram taken during pregnancy and the child born with Hirschsprung's disease]. ( Nielsen, SW; Qvist, N, 2013) |
| "These data indicate that: (1) clinically relevant antidepressant treatment during human pregnancy can be modeled in rats using escitalopram; (2) chronic mild stress can be delivered in a manner that does not compromise fetal viability; and (3) neither of these prenatal treatments substantially altered maternal care post parturition." | 3.79 | Prenatal exposure to escitalopram and/or stress in rats: a prenatal stress model of maternal depression and its treatment. ( Boss-Williams, KA; Bourke, CH; Capello, CF; Owens, MJ; Rogers, SM; Stowe, ZN; Weiss, JM; Yu, ML, 2013) |
| " We examined whether treatment with a selective serotonin reuptake inhibitor [escitalopram (ESC)] could downregulate HPA axis activity and restore insulin sensitivity in LBW rats." | 3.76 | Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats. ( Buhl, CS; Buhl, ES; Elfving, B; Jensen, TK; Jessen, N; Kristiansen, SB; Lund, S; Petersen, KF; Pold, R; Schmitz, O; Solskov, L; Wegener, G, 2010) |
| "A term neonate presenting with necrotizing enterocolitis following in utero and breast milk exposure to the newest serotonin selective reuptake inhibitor, escitalopram, is described." | 3.74 | Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram. ( Carter, BS; Potts, AL; Shenai, JP; Young, KL, 2007) |
| "We describe the case of a pregnancy healthy outcome after in utero consecutive exposure to lamotrigine and citalopram." | 3.74 | Consecutive exposure to lamotrigine and citalopram during pregnancy. ( Gentile, S; Vozzi, F, 2007) |
| "Citalopram use during the period of embryogenesis in pregnancy is not associated with an apparent major teratogenic risk." | 3.73 | Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. ( Einarson, A; Koren, G; Sarkissian, L; Shuhaiber, S; Sivojelezova, A, 2005) |
| "We describe the first reported case of acute cholestasis due to citalopram (selective serotonin reuptake inhibitor) occurring in a patient who also experienced obstetric cholestasis in association with each of three pregnancies; in a second patient cholestasis developed due to dothiepin (tricyclic antidepressant), and six years later due to paroxetine." | 3.72 | Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). ( Chilton, AP; Elias, E; Hubscher, SG; Milkiewicz, P, 2003) |
| "Citalopram, fluoxetine and desmethylfluoxetine all cross the human placenta, and may, therefore, affect the perinatal outcome of infants exposed to these drugs during pregnancy." | 3.71 | Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. ( Ekblad, U; Heikkine, T; Laine, K, 2002) |
| " A population pharmacokinetic model that aimed to better characterize maternal and infant exposure to SCIT and its metabolite was developed." | 1.56 | A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk. ( Beaufils, E; Bickle Graz, M; Borradori Tolsa, C; Claris, O; Csajka, C; Eap, CB; Epiney, M; Fischer, CJ; Gaucherand, P; Guidi, M; Hascoët, JM; Kassai-Koupai, B; Morisod Harari, M; Nguyen, KA; Panchaud, A; Rothenburger, S; Rouiller, S; Tolsa, JF; Vial, Y; Weisskopf, E, 2020) |
| " Serum concentration of citalopram and daily dosage correlated positively while daily dosage and mother milk concentration did not (rho = 0." | 1.51 | Antidepressants in breast milk; comparative analysis of excretion ratios. ( Augustin, M; Franz, C; Gründer, G; Paulzen, M; Saßmannshausen, H; Schoretsanitis, G, 2019) |
| "The median daily dosage of citalopram was 20mg (Q1: 10mg, Q3: 20mg; range 10-40mg)." | 1.46 | Pregnancy exposure to citalopram - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood. ( Goecke, TW; Gründer, G; Janssen, G; Paulzen, M; Schoretsanitis, G; Stickeler, E; Stingl, JC, 2017) |
| "Depression during pregnancy has been linked to in utero stress and is associated with long-lasting symptoms in offspring, including anxiety, helplessness, attentional deficits, and social withdrawal." | 1.42 | Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats. ( Bourke, CH; Ehrlich, DE; Hazra, R; Jairam, N; Neigh, GN; Nemeth, CL; Owens, MJ; Rainnie, DG; Rowson, S; Ryan, SJ; Sholar, CA; Stowe, ZN, 2015) |
| "We suggest the hypothesis that neonatal withdrawal syndrome may follow citalopram serotonin toxicity." | 1.39 | Neonatal toxicity following maternal citalopram treatment. ( Bonati, M; Butera, R; Cotti Cottini, F; Eleftheriou, G; Farina, M, 2013) |
| "Escitalopram is a serotonin reuptake inhibitor prescribed for depression and anxiety." | 1.38 | Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. ( Einarson, A; Einarson, T; Klieger-Grossmann, C; Koren, G; Panchaud, A; Pistelli, A; Weitzner, B, 2012) |
| "Escitalopram is an antidepressant drug shown to reverse the depressive-like features caused by this stress model." | 1.38 | Escitalopram improves memory deficits induced by maternal separation in the rat. ( Batalha, VL; Couto, FS; Data-Franca, J; Lopes, LV; Ribeiro, JA; Valadas, JS, 2012) |
| "It is important that variations in drug metabolism during pregnancy be considered as these changes may necessitate a dosage adjustment to ensure that therapeutic failure does not occur during pregnancy." | 1.36 | Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach. ( Baumer, C; Koren, G; O'Brien, L; Sachs, H; Thieme, D, 2010) |
| "Citalopram promotes proliferation and differentiation of NPCs from embryonic rat hippocampus." | 1.34 | [The effects of citalopram on proliferation and differentiation of neural precursor cells from embryonic rat hippocampus]. ( Chen, BA; Guo, YJ; Teng, GJ; Wang, SH; Zhang, ZJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (8.14) | 18.2507 |
| 2000's | 27 (31.40) | 29.6817 |
| 2010's | 42 (48.84) | 24.3611 |
| 2020's | 10 (11.63) | 2.80 |
| Authors | Studies |
|---|---|
| Marks, C | 1 |
| Silvola, R | 1 |
| Teal, E | 1 |
| Quinney, SK | 1 |
| Haas, DM | 1 |
| Zahra, A | 3 |
| Du, L | 1 |
| Jia, M | 1 |
| Butt, MU | 1 |
| Wang, Q | 2 |
| Wang, Y | 3 |
| Wu, J | 1 |
| Olstad, EW | 1 |
| Nordeng, HME | 1 |
| Sandve, GK | 1 |
| Lyle, R | 1 |
| Gervin, K | 1 |
| Galbally, M | 1 |
| Watson, SJ | 1 |
| Nguyen, T | 1 |
| Boyce, P | 1 |
| Hudon Thibeault, AA | 1 |
| López de Los Santos, Y | 1 |
| Doucet, N | 1 |
| Sanderson, JT | 1 |
| Vaillancourt, C | 1 |
| Cabrera, RM | 1 |
| Linda Lin, Y | 1 |
| Law, E | 1 |
| Kim, J | 1 |
| Wlodarczyk, BJ | 1 |
| Weisskopf, E | 1 |
| Guidi, M | 1 |
| Fischer, CJ | 1 |
| Bickle Graz, M | 1 |
| Beaufils, E | 1 |
| Nguyen, KA | 1 |
| Morisod Harari, M | 1 |
| Rouiller, S | 1 |
| Rothenburger, S | 1 |
| Gaucherand, P | 1 |
| Kassai-Koupai, B | 1 |
| Borradori Tolsa, C | 1 |
| Epiney, M | 1 |
| Tolsa, JF | 1 |
| Vial, Y | 1 |
| Hascoët, JM | 1 |
| Claris, O | 1 |
| Eap, CB | 1 |
| Panchaud, A | 2 |
| Csajka, C | 1 |
| Sjaarda, LA | 1 |
| Radoc, JG | 1 |
| Flannagan, KS | 1 |
| Mumford, SL | 1 |
| Kim, K | 1 |
| Perkins, NJ | 1 |
| Silver, RM | 1 |
| Schisterman, EF | 1 |
| Colombo, A | 1 |
| Giordano, F | 1 |
| Giorgetti, F | 1 |
| Di Bernardo, I | 1 |
| Bosi, MF | 1 |
| Varinelli, A | 1 |
| Cafaro, R | 1 |
| Pileri, P | 1 |
| Cetin, I | 1 |
| Clementi, E | 1 |
| Viganò, CA | 1 |
| Dell'Osso, B | 1 |
| Burstein, O | 1 |
| Simon, N | 1 |
| Simchon-Tenenbaum, Y | 1 |
| Rehavi, M | 1 |
| Franko, M | 1 |
| Shamir, A | 1 |
| Doron, R | 1 |
| Liu, K | 1 |
| Garcia, A | 1 |
| Park, JJ | 1 |
| Toliver, AA | 1 |
| Ramos, L | 1 |
| Aizenman, CD | 1 |
| Shea, AK | 1 |
| Wolfman, W | 1 |
| Paulzen, M | 2 |
| Goecke, TW | 1 |
| Stingl, JC | 1 |
| Janssen, G | 1 |
| Stickeler, E | 1 |
| Gründer, G | 2 |
| Schoretsanitis, G | 2 |
| Westin, AA | 1 |
| Brekke, M | 1 |
| Molden, E | 1 |
| Skogvoll, E | 1 |
| Spigset, O | 1 |
| Nagano, R | 1 |
| Nagano, M | 1 |
| Nakai, A | 1 |
| Takeshita, T | 1 |
| Suzuki, H | 1 |
| Dong, X | 1 |
| Liu, M | 1 |
| Sun, A | 1 |
| Li, N | 1 |
| Lin, Y | 1 |
| Geng, Z | 1 |
| Jin, Y | 1 |
| Li, X | 1 |
| Womersley, K | 1 |
| Ripullone, K | 1 |
| Agius, M | 1 |
| Park, SW | 2 |
| Seo, MK | 2 |
| Lee, JG | 2 |
| Hien, LT | 1 |
| Kim, YH | 2 |
| Kellner, M | 1 |
| Porseryd, T | 1 |
| Porsch-Hällström, I | 1 |
| Borg, B | 1 |
| Roufidou, C | 1 |
| Olsén, KH | 1 |
| Erol, S | 1 |
| Ozcan, B | 1 |
| Celik, IH | 1 |
| Bas, AY | 1 |
| Demirel, N | 1 |
| Jwa, S | 1 |
| Wada, Y | 1 |
| Yamamoto, M | 1 |
| Sumida, Y | 1 |
| Jiang, J | 2 |
| Chen, Y | 2 |
| Long, C | 2 |
| Yang, L | 2 |
| Augustin, M | 1 |
| Saßmannshausen, H | 1 |
| Franz, C | 1 |
| Furuse, K | 1 |
| Ukai, W | 1 |
| Hashimoto, E | 1 |
| Hashiguchi, H | 1 |
| Kigawa, Y | 1 |
| Ishii, T | 1 |
| Tayama, M | 1 |
| Deriha, K | 1 |
| Shiraishi, M | 1 |
| Kawanishi, C | 1 |
| Zheng, Y | 1 |
| Velasquez, JC | 3 |
| Zhao, Q | 1 |
| Chan, Y | 1 |
| Galindo, LCM | 1 |
| Simasotchi, C | 1 |
| Wu, D | 1 |
| Hou, Z | 1 |
| Herod, SM | 2 |
| Oberlander, TF | 1 |
| Gil, S | 1 |
| Fournier, T | 1 |
| Burd, I | 1 |
| Andrews, AM | 1 |
| Bonnin, A | 3 |
| Bourke, CH | 2 |
| Capello, CF | 1 |
| Rogers, SM | 1 |
| Yu, ML | 1 |
| Boss-Williams, KA | 1 |
| Weiss, JM | 1 |
| Stowe, ZN | 4 |
| Owens, MJ | 4 |
| Eleftheriou, G | 1 |
| Butera, R | 1 |
| Cotti Cottini, F | 1 |
| Bonati, M | 1 |
| Farina, M | 1 |
| Rodgers, AB | 1 |
| Morgan, CP | 1 |
| Bronson, SL | 1 |
| Revello, S | 1 |
| Bale, TL | 1 |
| Kouros, N | 1 |
| Cray, JJ | 1 |
| Weinberg, SM | 1 |
| Parsons, TE | 1 |
| Howie, RN | 1 |
| Elsalanty, M | 1 |
| Yu, JC | 1 |
| Nielsen, SW | 1 |
| Qvist, N | 1 |
| Zohar, I | 2 |
| Dosoretz-Abittan, L | 1 |
| Shoham, S | 2 |
| Weinstock, M | 2 |
| Ehrlich, DE | 1 |
| Neigh, GN | 2 |
| Nemeth, CL | 2 |
| Hazra, R | 1 |
| Ryan, SJ | 1 |
| Rowson, S | 1 |
| Jairam, N | 1 |
| Sholar, CA | 1 |
| Rainnie, DG | 1 |
| Goeden, N | 1 |
| Ly, NN | 1 |
| Lee, CH | 1 |
| Cho, HY | 1 |
| Choi, CM | 1 |
| Nhu, LH | 1 |
| Lee, BJ | 1 |
| Kim, GM | 1 |
| Yoon, BJ | 1 |
| Kelly, SD | 1 |
| Hardy, EE | 1 |
| Bourke, C | 1 |
| Sprowles, JL | 1 |
| Hufgard, JR | 1 |
| Gutierrez, A | 1 |
| Bailey, RA | 1 |
| Jablonski, SA | 1 |
| Williams, MT | 1 |
| Vorhees, CV | 1 |
| King, JR | 1 |
| Torii, M | 1 |
| Kajta, M | 1 |
| Wnuk, A | 1 |
| Rzemieniec, J | 1 |
| Litwa, E | 1 |
| Lason, W | 1 |
| Zelek-Molik, A | 1 |
| Nalepa, I | 1 |
| Rogóż, Z | 1 |
| Grochowalski, A | 1 |
| Wojtowicz, AK | 1 |
| Frison, G | 1 |
| Favretto, D | 1 |
| Vogliardi, S | 1 |
| Terranova, C | 1 |
| Ferrara, SD | 1 |
| Gentile, S | 3 |
| Tixier, H | 1 |
| Feyeux, C | 1 |
| Girod, S | 1 |
| Thouvenot, S | 1 |
| Morisse, M | 1 |
| Douvier, S | 1 |
| Sagot, P | 1 |
| Davidson, S | 1 |
| Prokonov, D | 1 |
| Taler, M | 1 |
| Maayan, R | 1 |
| Harell, D | 1 |
| Gil-Ad, I | 1 |
| Weizman, A | 1 |
| Lanza di Scalea, T | 1 |
| Wisner, KL | 2 |
| Werremeyer, A | 1 |
| O'Brien, L | 1 |
| Baumer, C | 1 |
| Thieme, D | 1 |
| Sachs, H | 1 |
| Koren, G | 3 |
| Buhl, ES | 1 |
| Jensen, TK | 1 |
| Jessen, N | 1 |
| Elfving, B | 1 |
| Buhl, CS | 1 |
| Kristiansen, SB | 1 |
| Pold, R | 1 |
| Solskov, L | 1 |
| Schmitz, O | 1 |
| Wegener, G | 1 |
| Lund, S | 1 |
| Petersen, KF | 1 |
| Chisolm, MS | 1 |
| Brigham, EP | 1 |
| Tuten, M | 1 |
| Strain, EC | 1 |
| Jones, HE | 1 |
| Tuccori, M | 1 |
| Montagnani, S | 1 |
| Testi, A | 1 |
| Ruggiero, E | 1 |
| Mantarro, S | 1 |
| Scollo, C | 1 |
| Pergola, A | 1 |
| Fornai, M | 1 |
| Antonioli, L | 1 |
| Colucci, R | 1 |
| Corona, T | 1 |
| Blandizzi, C | 1 |
| Weaver, KJ | 1 |
| Paul, IA | 4 |
| Lin, RC | 3 |
| Simpson, KL | 3 |
| Patel, BN | 1 |
| Beste, J | 1 |
| Blackwell, JC | 1 |
| Klieger-Grossmann, C | 1 |
| Weitzner, B | 1 |
| Pistelli, A | 1 |
| Einarson, T | 1 |
| Einarson, A | 2 |
| Darling, RD | 1 |
| Alzghoul, L | 1 |
| Zhang, J | 1 |
| Khatri, N | 1 |
| Misri, S | 1 |
| Abizadeh, J | 1 |
| Albert, G | 1 |
| Carter, D | 1 |
| Ryan, D | 1 |
| Couto, FS | 1 |
| Batalha, VL | 1 |
| Valadas, JS | 1 |
| Data-Franca, J | 1 |
| Ribeiro, JA | 1 |
| Lopes, LV | 1 |
| Bellantuono, C | 1 |
| Bozzi, F | 1 |
| Orsolini, L | 1 |
| Catena-Dell'Osso, M | 1 |
| Heikkinen, T | 1 |
| Ekblad, U | 2 |
| Kero, P | 1 |
| Ekblad, S | 1 |
| Laine, K | 2 |
| Heikkine, T | 1 |
| Milkiewicz, P | 1 |
| Chilton, AP | 1 |
| Hubscher, SG | 1 |
| Elias, E | 1 |
| Hendrick, V | 1 |
| Altshuler, LL | 1 |
| Hwang, S | 1 |
| Lee, E | 1 |
| Haynes, D | 1 |
| Arborelius, L | 1 |
| Hawks, BW | 1 |
| Plotsky, PM | 1 |
| Nemeroff, CB | 1 |
| Wu, CC | 1 |
| Chen, JY | 1 |
| Tao, PL | 1 |
| Chen, YA | 1 |
| Yeh, GC | 1 |
| Maciag, D | 2 |
| Coppinger, D | 2 |
| Lu, Y | 1 |
| Sivojelezova, A | 1 |
| Shuhaiber, S | 1 |
| Sarkissian, L | 1 |
| Hsiao, SY | 1 |
| Cherng, CF | 1 |
| Yang, YK | 1 |
| Yeh, TL | 1 |
| Yu, L | 1 |
| Potts, AL | 1 |
| Young, KL | 1 |
| Carter, BS | 1 |
| Shenai, JP | 1 |
| Majewski, S | 1 |
| Donnenfeld, AE | 1 |
| Kuhlman, K | 1 |
| Patel, A | 1 |
| Kraft, K | 1 |
| Vozzi, F | 1 |
| Wang, SH | 1 |
| Zhang, ZJ | 1 |
| Guo, YJ | 1 |
| Teng, GJ | 1 |
| Chen, BA | 1 |
| Kwon, P | 1 |
| Lefkowitz, W | 1 |
| Sit, DK | 1 |
| Perel, JM | 1 |
| Helsel, JC | 1 |
| Blatt, GJ | 1 |
| Chen, JC | 1 |
| Rosene, DL | 1 |
| Volicer, L | 1 |
| Galler, JR | 1 |
| Cabrera, TM | 1 |
| Levy, AD | 1 |
| Li, Q | 1 |
| van de Kar, LD | 1 |
| Battaglia, G | 1 |
| Seifritz, E | 1 |
| Holsboer-Trachsler, E | 1 |
| Haberthur, F | 1 |
| Hemmeter, U | 1 |
| Pöldinger, W | 1 |
| Kim, JA | 1 |
| Druse, MJ | 1 |
| Mortensen, OV | 1 |
| Kristensen, AS | 1 |
| Rudnick, G | 1 |
| Wiborg, O | 1 |
| Snider, RD | 1 |
| Yan, QS | 1 |
| Bal, AK | 1 |
| Bird, MM | 2 |
| Bal-Klara, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antidepressant Treatments During Pregnancy and Lactation: Prediction of Drug Exposure Through Breastfeeding and Evaluation of Drug Effect on the Neonatal Adaptation and the Development of the Young Child[NCT01796132] | Phase 4 | 500 participants (Anticipated) | Interventional | 2012-08-31 | Recruiting | ||
| The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
| Perinatal Stress and Gene Influences: Pathways to Infant Vulnerability[NCT00525226] | 1,431 participants (Actual) | Observational | 2007-09-30 | Completed | |||
| Antidepressant Use During Pregnancy[NCT00279370] | 283 participants (Actual) | Observational | 1999-09-30 | Completed | |||
| A Prospective Study of Pregnant and Postpartum Women With and Without Mood Disorders[NCT03615794] | 400 participants (Anticipated) | Observational | 2017-10-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 7 |
| Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 374 |
| Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 28 |
| Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 3 |
| Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 4 |
| Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 394 |
| Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
| Intervention | livebirths (Number) |
|---|---|
| Aspirin | 309 |
| Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 0 |
| Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 32 |
| Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 56 |
| Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
| Intervention | infants (Number) |
|---|---|
| Aspirin | 22 |
| Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
| Intervention | grams (Mean) |
|---|---|
| Aspirin | 3327 |
| Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
| Intervention | participants (Number) |
|---|---|
| Aspirin | 2 |
| Placebo | 2 |
5 reviews available for citalopram and Pregnancy
| Article | Year |
|---|---|
What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
Topics: Adult; Anxiety; Citalopram; Depression; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complicatio | 2017 |
Antidepressant medication use during breastfeeding.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Citalopram; Depression, Postpartum; Female | 2009 |
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetin | 2010 |
The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Breast Feeding; Citalopram; E | 2012 |
[New developments in hypericum extracts: data on efficacy and interactions].
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bridg | 2007 |
5 trials available for citalopram and Pregnancy
| Article | Year |
|---|---|
Paternal stress exposure alters sperm microRNA content and reprograms offspring HPA stress axis regulation.
Topics: Acoustic Stimulation; Adaptation, Ocular; Analysis of Variance; Animals; Animals, Newborn; Citalopra | 2013 |
The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depressive Disorder, Major; | 2010 |
Restoration of functionality in postpartum depressed mothers: an open-label study with escitalopram.
Topics: Adult; Citalopram; Depression, Postpartum; Female; Humans; Pregnancy; Prospective Studies; Quality o | 2012 |
Citalopram in pregnancy and lactation.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Child Development; Citalopram | 2002 |
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression, Postpartum; Depressive Diso | 2008 |
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression, Postpartum; Depressive Diso | 2008 |
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression, Postpartum; Depressive Diso | 2008 |
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression, Postpartum; Depressive Diso | 2008 |
76 other studies available for citalopram and Pregnancy
| Article | Year |
|---|---|
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxe | 2021 |
Prenatal exposure of citalopram elicits depression-like and anxiety-like behaviors and alteration of morphology and protein expression of medial prefrontal cortex in young adult mice.
Topics: Animals; Anxiety; Citalopram; Depression; Depressive Disorder, Major; Female; Male; Mice; Mice, Inbr | 2022 |
Effects of prenatal exposure to (es)citalopram and maternal depression during pregnancy on DNA methylation and child neurodevelopment.
Topics: Child; Citalopram; Cohort Studies; Depression; DNA Methylation; Female; Humans; Infant, Newborn; Pre | 2023 |
Fetal SSRI antidepressant exposure and infant sleep: Findings from the MPEWS pregnancy cohort study.
Topics: Antidepressive Agents; Citalopram; Cohort Studies; Escitalopram; Female; Humans; Infant; Longitudina | 2023 |
Serotonin and serotonin reuptake inhibitors alter placental aromatase.
Topics: Aromatase; Cells, Cultured; Citalopram; Female; Fluoxetine; Humans; Molecular Docking Simulation; Pa | 2019 |
The teratogenic effects of sertraline in mice.
Topics: Animals; Citalopram; Female; Humans; Mice; Mice, Inbred ICR; Paroxetine; Pregnancy; Selective Seroto | 2020 |
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk.
Topics: Animals; Breast Feeding; Citalopram; Female; Humans; Infant; Milk, Human; Pharmaceutical Preparation | 2020 |
Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.
Topics: Abortion, Spontaneous; Adult; Citalopram; Female; Fertility; Fluoxetine; Humans; Live Birth; Pregnan | 2020 |
Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affec
Topics: Citalopram; Escitalopram; Female; Humans; Mood Disorders; Pharmacogenetics; Pregnancy; Selective Ser | 2021 |
Moderation of the transgenerational transference of antenatal stress-induced anxiety.
Topics: Animals; Anxiety; Citalopram; COVID-19; Crataegus; Disease Models, Animal; Drugs, Chinese Herbal; Fe | 2021 |
Early Developmental Exposure to Fluoxetine and Citalopram Results in Different Neurodevelopmental Outcomes.
Topics: Anxiety; Citalopram; Female; Fluoxetine; Humans; Patch-Clamp Techniques; Pregnancy; Selective Seroto | 2021 |
The role of hormone therapy in the management of severe postpartum depression in patients with Turner syndrome.
Topics: Adult; Citalopram; Depression, Postpartum; Diagnosis, Differential; Estrogen Replacement Therapy; Fe | 2017 |
Pregnancy exposure to citalopram - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood.
Topics: Adult; Amniotic Fluid; Citalopram; Cordocentesis; Dose-Response Relationship, Drug; Drug Monitoring; | 2017 |
Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
Topics: Adult; Antidepressive Agents; Citalopram; Databases, Factual; Depressive Disorder; Drug Monitoring; | 2017 |
Differential effects of neonatal SSRI treatments on hypoxia-induced behavioral changes in male and female offspring.
Topics: Animals; Animals, Newborn; Behavior, Animal; Citalopram; Disease Models, Animal; Female; Fluoxetine; | 2017 |
Adolescent escitalopram prevents the effects of maternal separation on depression- and anxiety-like behaviours and regulates the levels of inflammatory cytokines in adult male mice.
Topics: Age Factors; Animals; Animals, Newborn; Anxiety, Separation; Brain; Citalopram; Cytokines; Depressio | 2017 |
Effects of maternal separation and antidepressant drug on epigenetic regulation of the brain-derived neurotrophic factor exon I promoter in the adult rat hippocampus.
Topics: Acetylation; Animals; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; C | 2018 |
Developmental exposure to the SSRI citalopram causes long-lasting behavioural effects in the three-spined stickleback (Gasterosteus aculeatus).
Topics: Animals; Behavior, Animal; Citalopram; Female; Pregnancy; Selective Serotonin Reuptake Inhibitors; S | 2018 |
Neonatal abstinence syndrome due to prenatally citalopram exposure: A case report.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; F | 2017 |
Neonatal morbidity due to maternal use of two antidepressant drugs.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Citalopram; Drug Therapy, Combination; | 2018 |
Memantine rescues prenatal citalopram exposure-induced striatal and social abnormalities in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Corpus Striatum; Excitatory | 2018 |
Antidepressants in breast milk; comparative analysis of excretion ratios.
Topics: Adult; Antidepressive Agents; Breast Feeding; Child Development; Citalopram; Depression; Female; Hum | 2019 |
Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Cor | 2019 |
Exposure to prenatal antidepressant alters medial prefrontal-striatal synchronization in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Brain; Citalopram; Corpus Striatum; Dendrites; Depression; | 2019 |
Topics: Animals; Brain; Citalopram; Disease Models, Animal; Female; Fetal Development; Magnetic Resonance Im | 2019 |
Prenatal exposure to escitalopram and/or stress in rats: a prenatal stress model of maternal depression and its treatment.
Topics: Animals; Citalopram; Corticosterone; Darkness; Depression; Disease Models, Animal; Female; Infusion | 2013 |
Neonatal toxicity following maternal citalopram treatment.
Topics: Citalopram; Depressive Disorder, Major; Diagnosis, Differential; Female; Half-Life; Humans; Infant, | 2013 |
Warning of risk to foetus for mothers using SSRIs.
Topics: Abnormalities, Drug-Induced; Citalopram; Depressive Disorder; Female; Humans; Pregnancy; Pregnancy C | 2013 |
Selective serotonin reuptake inhibitor exposure alters osteoblast gene expression and craniofacial development in mice.
Topics: Animals; Biomarkers; Cells, Cultured; Citalopram; Craniofacial Abnormalities; Female; Gene Expressio | 2014 |
[Citalopram taken during pregnancy and the child born with Hirschsprung's disease].
Topics: Abnormalities, Drug-Induced; Citalopram; Female; Hirschsprung Disease; Humans; Infant, Newborn; Preg | 2013 |
Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram.
Topics: Animals; Anxiety; Citalopram; Corticotropin-Releasing Hormone; Dorsal Raphe Nucleus; Female; GABAerg | 2015 |
Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats.
Topics: Amygdala; Animals; Anxiety; Citalopram; Corticosterone; Disease Models, Animal; Estradiol; Female; g | 2015 |
Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring.
Topics: Animals; Anxiety; Autoreceptors; Behavior, Animal; Citalopram; Corticotropin-Releasing Hormone; Dise | 2016 |
Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.
Topics: Animals; Chromatography, High Pressure Liquid; Citalopram; Female; Fetus; Mice; Pregnancy; Prenatal | 2016 |
Early life stress increases stress vulnerability through BDNF gene epigenetic changes in the rat hippocampus.
Topics: Adult; Animals; Antidepressive Agents, Second-Generation; Anxiety, Separation; Brain-Derived Neurotr | 2016 |
Prenatal stress-induced increases in hippocampal von Willebrand factor expression are prevented by concurrent prenatal escitalopram.
Topics: Age Factors; Amygdala; Angiogenic Proteins; Animals; Citalopram; Female; Hippocampus; Male; Prefront | 2017 |
Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats.
Topics: Age Factors; Amphetamines; Animals; Animals, Newborn; Anxiety; Body Weight; Citalopram; Depression; | 2016 |
Effect of Maternal ±Citalopram Exposure on P11 Expression and Neurogenesis in the Mouse Fetal Brain.
Topics: Animals; Axons; Citalopram; Female; Maternal Exposure; Mice; Neurogenesis; Neurons; Pregnancy; Selec | 2017 |
Depressive-like effect of prenatal exposure to DDT involves global DNA hypomethylation and impairment of GPER1/ESR1 protein levels but not ESR2 and AHR/ARNT signaling.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Citalopram; DDT; Depress | 2017 |
Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-tandem mass spectrometry.
Topics: Adult; Calibration; Chromatography, High Pressure Liquid; Citalopram; Female; Hair; Humans; Infant, | 2008 |
Use of escitalopram during pregnancy: navigating towards international guidelines and the real world.
Topics: Adult; Citalopram; Female; Fetus; Humans; Infant, Newborn; International Cooperation; Lactation; Liv | 2008 |
Acute voluntary intoxication with selective serotonin reuptake inhibitors during the third trimester of pregnancy: therapeutic management of mother and fetus.
Topics: Adrenal Cortex Hormones; Adult; Antidotes; Calcium Channel Blockers; Charcoal; Citalopram; Depressio | 2008 |
Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.
Topics: Adult; Birth Weight; Case-Control Studies; Citalopram; Female; Fetal Blood; Fetal Development; Fetal | 2009 |
Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Citalopram; Drug Therapy, Combination; | 2009 |
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Female; Fluoxetine; Gas Chromatography-Mass | 2010 |
Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Area Under Curve; Blood Glucose; Body We | 2010 |
Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects.
Topics: Animals; Animals, Newborn; Caudate Nucleus; Cerebral Cortex; Citalopram; Cognition; Dose-Response Re | 2010 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclo | 2011 |
Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Analysis of Variance; Ant | 2012 |
Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats.
Topics: Action Potentials; Animals; Animals, Newborn; Citalopram; Dopamine beta-Hydroxylase; Female; Locus C | 2011 |
Escitalopram improves memory deficits induced by maternal separation in the rat.
Topics: Animals; Antidepressive Agents; Anxiety, Separation; Behavior, Animal; Citalopram; Cognition; Female | 2012 |
Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta.
Topics: Citalopram; Female; Fluoxetine; Humans; Maternal-Fetal Exchange; Placenta; Pregnancy; Prospective St | 2002 |
Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2).
Topics: Acute Disease; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressiv | 2003 |
Placental passage of antidepressant medications.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Fem | 2003 |
Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoradiography; Binding Sites; Citalopram; Dose-Re | 2004 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; F | 2004 |
Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
Topics: Animals; Animals, Newborn; Behavior, Animal; Citalopram; Clomipramine; Female; Fluoxetine; Maternal- | 2005 |
Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antigens, Nuclea | 2006 |
Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.
Topics: Antidepressive Agents, Second-Generation; Birth Weight; Citalopram; Female; Gestational Age; Humans; | 2005 |
Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Cocaine; Conditio | 2005 |
Escitalopram late in pregnancy and while breast-feeding.
Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder, Major; Female; Humans; Infant, Newborn; Male | 2006 |
Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Age Factors; Analysis of Variance; Animals; Animals, Newborn | 2006 |
Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram.
Topics: Citalopram; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Milk, Human; Pregnancy; Pre | 2007 |
Second-trimester prenatal diagnosis of total arhinia.
Topics: Abortion, Eugenic; Adolescent; Antidepressive Agents, Second-Generation; Citalopram; Craniofacial Ab | 2007 |
Consecutive exposure to lamotrigine and citalopram during pregnancy.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Depression; Drug Administration Sched | 2007 |
[The effects of citalopram on proliferation and differentiation of neural precursor cells from embryonic rat hippocampus].
Topics: Animals; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Citalopram; Dose- | 2007 |
Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
Topics: Adult; Anti-Anxiety Agents; Basal Ganglia Diseases; Citalopram; Female; Humans; Infant, Newborn; Lor | 2008 |
Prenatal protein malnutrition effects on the serotonergic system in the hippocampal formation: an immunocytochemical, ligand binding, and neurochemical study.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Chromatography, High Pressure Liquid; Citalopram; F | 1994 |
Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain.
Topics: Analysis of Variance; Animals; Body Weight; Brain; Cerebral Cortex; Citalopram; Female; Hypothalamus | 1993 |
Unrecognized pregnancy during citalopram treatment.
Topics: Abortion, Induced; Adult; Citalopram; Depressive Disorder; Female; Fetus; Humans; Maternal-Fetal Exc | 1993 |
Protective effects of maternal buspirone treatment on serotonin reuptake sites in ethanol-exposed offspring.
Topics: Animals; Autoradiography; Brain; Brain Chemistry; Buspirone; Central Nervous System Depressants; Cit | 1996 |
Molecular cloning, expression and characterization of a bovine serotonin transporter.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Cattle; Citalopram; Cloning, Molecular; Desipramine; | 1999 |
Case report: left bundle branch block--a rare complication of citalopram overdose.
Topics: Adult; Bundle-Branch Block; Citalopram; Drug Overdose; Female; Humans; Pregnancy; Selective Serotoni | 2001 |
Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure.
Topics: Animals; Animals, Newborn; Citalopram; Cocaine; Cocaine-Related Disorders; Electric Stimulation; Fem | 2002 |
Changes in the amount and distribution of neuronal alkaline and acid phosphatase after chronic exposure of cultures of cingulate cortex to antidepressant drugs.
Topics: Acid Phosphatase; Alkaline Phosphatase; Amitriptyline; Animals; Antidepressive Agents; Cells, Cultur | 1992 |
The effects of various antidepressant drugs on the fine-structure of neurons of the cingulate cortex in culture.
Topics: Amitriptyline; Animals; Antidepressive Agents; Citalopram; Cytoskeleton; Desipramine; Female; Gyrus | 1990 |